Attenuated Mannheimia haemolytica strains
US10039819B2 · kind B2 · utility
0Cited by
5References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 15, 2017 |
| Grant date | Aug 7, 2018 |
| Priority date | — |
| Expiry date | Jun 15, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides attenuated M haemolitica strains that elicit an immune response in animal against M haemolitica, compositions comprising said strains, methods of vaccination against M haemolitica, and kits for use with such methods and compositions. The invention further provides multi-valent vaccines, which provide protective immunity when administered in an effective amount to animals susceptible to “shipping fever” or bovine respiratory disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.